In recent years, India’s policy framework has increasingly focused on integrated, infrastructure-led manufacturing, recognizing that sustained industrial competitiveness depends not just on firm-level interventions, but also on robust infrastructure, coordination, and effective implementation.
This strategic shift is reflected in mission-driven initiatives such as the National Manufacturing Mission, PM MITRA Parks, PM Gati Shakti, and digital public platforms like ULIP.
These programs emphasize the development of industrial corridors, parks, and clusters, combining physical infrastructure with institutional support.
The approach aims to address long-standing challenges such as logistics bottlenecks, financing delays, and lack of coordination factors that have historically constrained industrial growth.
Manufacturing Ecosystems
The Union Budget 2026–27 builds on this foundation by promoting infrastructure-based manufacturing through targeted support for manufacturing parks, shared facilities, and improved connectivity. It reinforces a hub-based model, focusing on scale, reliability, and stronger value chain linkages.
Three new chemical parks will be established to boost cluster-based manufacturing. These parks will offer shared infrastructure, safety systems, and enhanced logistics connectivity.
Textiles: Implementation of the seven already approved PM MITRA (Mega Integrated Textile Region and Apparel) Parks will continue, aiming to create large, integrated textile manufacturing hubs.
Cluster-based manufacturing and Common Facility Centres (CFCs) will be strengthened to provide MSMEs with access to shared production, testing, and quality infrastructure.
Capital Goods & Industrial Infrastructure support will be extended to tool rooms, testing, and calibration facilities to enhance domestic capital goods manufacturing capabilities.
Infrastructure Planning (PM Gati Shakti):
The PM Gati Shakti initiative will continue to enable coordinated, multimodal infrastructure planning for industrial and manufacturing zones.
Biopharma Manufacturing – ‘BioPharma Shakti’:
An allocation of Rs 10,000 crore over five years has been announced to develop a biopharma manufacturing ecosystem. This includes setting up three new National Institutes of Pharmaceutical Education and Research (NIPERs) and a nationwide network of over 1,000 accredited clinical trial sites.
